The Parkinson's progression markers initiative (PPMI) – establishing a PD biomarker cohort

By K. Marek, S. Chowdhury, A. Siderowf, Shirley Lasch, C. Coffey, C. Caspell-Garcia, T. Simuni, D. Jennings, C. Tanner, John Q. Trojanowski and 158 more. Annals of Clinical and Translational Neurology, 2018

595 citations recorded by the source corpus.

The Parkinson's Progression Markers Initiative (PPMI) is an observational, international study designed to establish biomarker‐defined cohorts and identify clinical, imaging, genetic, and biospecimen Parkinson's disease (PD) progression markers to accelerate disease‐modifying therapeutic trials.

Subfields: Cellular and Molecular Neuroscience, Neurology

View Paper: https://www.semanticscholar.org/paper/d16b21bb344d75bec0644aa5c57e11f3256d99f1